APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prostacyclin Drug Industry Growth and Trends Forecast to 2032

2 January 202699 pages

Choose your research edition.

Industry ResearchProstacyclin Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Prostacyclin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prostacyclin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostacyclin Drug include Teva, GSK, Bayer AG, United Therapeutics, Toray, Tide Pharma and Actelion (J & J), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostacyclin Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostacyclin Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostacyclin Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostacyclin Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostacyclin Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostacyclin Drug Market by Company

Teva

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Actelion (J & J)

Prostacyclin Drug Segment by Type

Beraprost Sodium

Epoprostenol Sodium

Treprostinil

Iloprost

Prostacyclin Drug Segment by Application

For Injection

For Inhalation

For Oral

Prostacyclin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostacyclin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostacyclin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Beraprost Sodium Table 2. Major Company of Epoprostenol Sodium Table 3. Major Company of Treprostinil Table 4. Major Company of Iloprost Table 5. Global Prostacyclin Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Prostacyclin Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Prostacyclin Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Prostacyclin Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Prostacyclin Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Prostacyclin Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Prostacyclin Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Prostacyclin Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Prostacyclin Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Prostacyclin Drug Industry Trends Table 27. Prostacyclin Drug Industry Drivers Table 28. Prostacyclin Drug Industry Opportunities and Challenges Table 29. Prostacyclin Drug Industry Restraints Table 30. Global Prostacyclin Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Prostacyclin Drug Revenue Market Share by Company (2021-2026) Table 32. Global Prostacyclin Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Prostacyclin Drug Sales Share by Company (2021-2026) Table 34. Global Prostacyclin Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Prostacyclin Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Prostacyclin Drug Major Company Production Sites and Headquarters Table 37. Global Prostacyclin Drug Company, Product Type & Application Table 38. Global Prostacyclin Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Prostacyclin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Prostacyclin Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Prostacyclin Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Prostacyclin Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Prostacyclin Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Prostacyclin Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Prostacyclin Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Prostacyclin Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Prostacyclin Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Prostacyclin Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Prostacyclin Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Prostacyclin Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Prostacyclin Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Prostacyclin Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Prostacyclin Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Prostacyclin Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Prostacyclin Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Prostacyclin Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Prostacyclin Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Prostacyclin Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Prostacyclin Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Prostacyclin Drug Product Portfolio Table 77. Teva Recent Development Table 78. GSK Company Information Table 79. GSK Business Overview Table 80. GSK Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GSK Prostacyclin Drug Product Portfolio Table 82. GSK Recent Development Table 83. Bayer AG Company Information Table 84. Bayer AG Business Overview Table 85. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer AG Prostacyclin Drug Product Portfolio Table 87. Bayer AG Recent Development Table 88. United Therapeutics Company Information Table 89. United Therapeutics Business Overview Table 90. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. United Therapeutics Prostacyclin Drug Product Portfolio Table 92. United Therapeutics Recent Development Table 93. Toray Company Information Table 94. Toray Business Overview Table 95. Toray Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Toray Prostacyclin Drug Product Portfolio Table 97. Toray Recent Development Table 98. Tide Pharma Company Information Table 99. Tide Pharma Business Overview Table 100. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Tide Pharma Prostacyclin Drug Product Portfolio Table 102. Tide Pharma Recent Development Table 103. Actelion (J & J) Company Information Table 104. Actelion (J & J) Business Overview Table 105. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Actelion (J & J) Prostacyclin Drug Product Portfolio Table 107. Actelion (J & J) Recent Development Table 108. North America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 110. North America Prostacyclin Drug Sales Market Share by Country (2021-2026) Table 111. North America Prostacyclin Drug Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Prostacyclin Drug Sales Market Share Forecast by Country (2027-2032) Table 113. North America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Prostacyclin Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Prostacyclin Drug Market Share by Country (2021-2026) Table 116. North America Prostacyclin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Prostacyclin Drug Market Share Forecast by Country (2027-2032) Table 118. Europe Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 120. Europe Prostacyclin Drug Sales Market Share by Country (2021-2026) Table 121. Europe Prostacyclin Drug Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Prostacyclin Drug Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Prostacyclin Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Prostacyclin Drug Market Share by Country (2021-2026) Table 126. Europe Prostacyclin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Prostacyclin Drug Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Prostacyclin Drug Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Prostacyclin Drug Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Prostacyclin Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Prostacyclin Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Prostacyclin Drug Market Share by Country (2021-2026) Table 136. Asia-Pacific Prostacyclin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Prostacyclin Drug Market Share Forecast by Country (2027-2032) Table 138. Latin America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 140. Latin America Prostacyclin Drug Sales Market Share by Country (2021-2026) Table 141. Latin America Prostacyclin Drug Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Prostacyclin Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Prostacyclin Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Prostacyclin Drug Market Share by Country (2021-2026) Table 146. Latin America Prostacyclin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Prostacyclin Drug Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Prostacyclin Drug Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Prostacyclin Drug Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Prostacyclin Drug Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Prostacyclin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Prostacyclin Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Prostacyclin Drug Market Share by Country (2021-2026) Table 156. Middle East and Africa Prostacyclin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Prostacyclin Drug Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Prostacyclin Drug Distributors List Table 161. Prostacyclin Drug Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Prostacyclin Drug Image Figure 2. Global Prostacyclin Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostacyclin Drug Sales (2021-2032) & (K Units) Figure 5. Beraprost Sodium Image Figure 6. Global Beraprost Sodium Sales YoY Growth (2021-2032) & (K Units) Figure 7. Epoprostenol Sodium Image Figure 8. Global Epoprostenol Sodium Sales YoY Growth (2021-2032) & (K Units) Figure 9. Treprostinil Image Figure 10. Global Treprostinil Sales YoY Growth (2021-2032) & (K Units) Figure 11. Iloprost Image Figure 12. Global Iloprost Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Prostacyclin Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Prostacyclin Drug Market Share by Type 2025 VS 2032 Figure 15. North America Prostacyclin Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Prostacyclin Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Prostacyclin Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Prostacyclin Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Prostacyclin Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Prostacyclin Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Prostacyclin Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Prostacyclin Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. For Injection Image Figure 28. Global For Injection Sales YoY Growth (2021-2032) & (K Units) Figure 29. For Inhalation Image Figure 30. Global For Inhalation Sales YoY Growth (2021-2032) & (K Units) Figure 31. For Oral Image Figure 32. Global For Oral Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Prostacyclin Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Prostacyclin Drug Market Share by Application 2025 VS 2032 Figure 35. North America Prostacyclin Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Prostacyclin Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Prostacyclin Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Prostacyclin Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Prostacyclin Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Prostacyclin Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Prostacyclin Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Prostacyclin Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Prostacyclin Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Prostacyclin Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Prostacyclin Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Prostacyclin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Prostacyclin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Prostacyclin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Prostacyclin Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Prostacyclin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Prostacyclin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Prostacyclin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Prostacyclin Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Prostacyclin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Prostacyclin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Prostacyclin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Prostacyclin Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Prostacyclin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Prostacyclin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Prostacyclin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Prostacyclin Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Prostacyclin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Prostacyclin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Prostacyclin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prostacyclin Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Prostacyclin Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Beraprost Sodium
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
Applications
  • For Injection
  • For Inhalation
  • For Oral
Companies covered
  • Teva
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma
  • Actelion (J & J)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostacyclin Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostacyclin Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostacyclin Drug Market by Type
  6. 1.3.1 Beraprost Sodium
  7. 1.3.2 Epoprostenol Sodium
  8. 1.3.3 Treprostinil
  9. 1.3.4 Iloprost
  10. 1.4 Global Prostacyclin Drug Market Size by Type
  11. 1.4.1 Global Prostacyclin Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Prostacyclin Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Prostacyclin Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Prostacyclin Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Prostacyclin Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Prostacyclin Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Prostacyclin Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Prostacyclin Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostacyclin Drug Industry Trends
  2. 2.2 Prostacyclin Drug Industry Drivers
  3. 2.3 Prostacyclin Drug Industry Opportunities and Challenges
  4. 2.4 Prostacyclin Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostacyclin Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostacyclin Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Prostacyclin Drug Price (2021-2026)
  4. 3.4 Global Prostacyclin Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostacyclin Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Prostacyclin Drug Company, Product Type & Application
  7. 3.7 Global Prostacyclin Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostacyclin Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostacyclin Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostacyclin Drug Tier 1, Tier 2, and Tier 3
4 Prostacyclin Drug Regional Status and Outlook
  1. 4.1 Global Prostacyclin Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostacyclin Drug Historic Market Size by Region
  3. 4.2.1 Global Prostacyclin Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostacyclin Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostacyclin Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostacyclin Drug Forecasted Market Size by Region
  7. 4.3.1 Global Prostacyclin Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostacyclin Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostacyclin Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostacyclin Drug by Application
  1. 5.1 Prostacyclin Drug Market by Application
  2. 5.1.1 For Injection
  3. 5.1.2 For Inhalation
  4. 5.1.3 For Oral
  5. 5.2 Global Prostacyclin Drug Market Size by Application
  6. 5.2.1 Global Prostacyclin Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prostacyclin Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prostacyclin Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prostacyclin Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prostacyclin Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prostacyclin Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prostacyclin Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prostacyclin Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Prostacyclin Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Prostacyclin Drug Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer AG Prostacyclin Drug Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 United Therapeutics
  20. 6.4.1 United Therapeutics Company Information
  21. 6.4.2 United Therapeutics Business Overview
  22. 6.4.3 United Therapeutics Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 United Therapeutics Prostacyclin Drug Product Portfolio
  24. 6.4.5 United Therapeutics Recent Developments
  25. 6.5 Toray
  26. 6.5.1 Toray Company Information
  27. 6.5.2 Toray Business Overview
  28. 6.5.3 Toray Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Toray Prostacyclin Drug Product Portfolio
  30. 6.5.5 Toray Recent Developments
  31. 6.6 Tide Pharma
  32. 6.6.1 Tide Pharma Company Information
  33. 6.6.2 Tide Pharma Business Overview
  34. 6.6.3 Tide Pharma Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tide Pharma Prostacyclin Drug Product Portfolio
  36. 6.6.5 Tide Pharma Recent Developments
  37. 6.7 Actelion (J & J)
  38. 6.7.1 Actelion (J & J) Company Information
  39. 6.7.2 Actelion (J & J) Business Overview
  40. 6.7.3 Actelion (J & J) Prostacyclin Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Actelion (J & J) Prostacyclin Drug Product Portfolio
  42. 6.7.5 Actelion (J & J) Recent Developments
7 North America by Country
  1. 7.1 North America Prostacyclin Drug Sales by Country
  2. 7.1.1 North America Prostacyclin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostacyclin Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Prostacyclin Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostacyclin Drug Market Size by Country
  6. 7.2.1 North America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostacyclin Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostacyclin Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostacyclin Drug Sales by Country
  2. 8.1.1 Europe Prostacyclin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostacyclin Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostacyclin Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostacyclin Drug Market Size by Country
  6. 8.2.1 Europe Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostacyclin Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostacyclin Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostacyclin Drug Sales by Country
  2. 9.1.1 Asia-Pacific Prostacyclin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostacyclin Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostacyclin Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostacyclin Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostacyclin Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostacyclin Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostacyclin Drug Sales by Country
  2. 10.1.1 South America Prostacyclin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostacyclin Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Prostacyclin Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostacyclin Drug Market Size by Country
  6. 10.2.1 South America Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostacyclin Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostacyclin Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostacyclin Drug Sales by Country
  2. 11.1.1 Middle East and Africa Prostacyclin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostacyclin Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostacyclin Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostacyclin Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Prostacyclin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostacyclin Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostacyclin Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostacyclin Drug Value Chain Analysis
  2. 12.1.1 Prostacyclin Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostacyclin Drug Production Mode & Process
  7. 12.2 Prostacyclin Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostacyclin Drug Distributors
  10. 12.2.3 Prostacyclin Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst